UNDERWRITING AGREEMENT between VIRIOS THERAPEUTICS, INC. and THINKEQUITY LLC as Representative of the Several UnderwritersUnderwriting Agreement • September 20th, 2022 • Virios Therapeutics, Inc. • Pharmaceutical preparations • New York
Contract Type FiledSeptember 20th, 2022 Company Industry JurisdictionThe undersigned, Virios Therapeutics, Inc., a corporation formed under the laws of the State of Delaware (collectively with its subsidiaries and affiliates, including, without limitation, all entities disclosed or described in the Registration Statement (as hereinafter defined) as being subsidiaries or affiliates of Virios Therapeutics, Inc., the “Company”), hereby confirms its agreement (this “Agreement”) with ThinkEquity LLC (hereinafter referred to as “you” (including its correlatives) or the “Representative”) and with the other underwriters named on Schedule 1 hereto for which the Representative is acting as representative (the Representative and such other underwriters being collectively called the “Underwriters” or, individually, an “Underwriter”) as follows: